Physician profile
Guy A Wells
NPI 1891785887
$4,607.03
in general payments reported to CMS, 2019-2025
25 companies · $610 in 2025
The $610 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2020: $628 · 2021: $598 · 2022: $1,260 · 2023: $594 · 2024: $441 · 2025: $610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,644.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $601.35 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $435.32 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $385.03 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $329.53 | 2019-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $317.70 | 2019-2024 | Xarelto |
| Allergan, INC. | $269.91 | 2020-2022 | |
| Biosense Webster, INC. | $259.18 | 2019-2022 | |
| Amgen INC. | $258.40 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $248.14 | 2021-2025 | Watchman Flx, Rotapro, Accolade Sr |
| Medtronic, INC. | $214.36 | 2022-2025 | Corevalve Evolut R, Symplicity G3, Chocolate Pta Balloon Catheter |
| Pfizer INC. | $212.02 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $210.25 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $200.38 | 2019-2024 | Farxiga |
| Penumbra, INC. | $135.54 | 2021 | |
| Merck Sharp & Dohme LLC | $96.55 | 2021-2023 | Verquvo |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $79.18 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Edwards Lifesciences Corporation | $78.38 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Gilead Sciences, INC. | $62.42 | 2019 | |
| Scpharmaceuticals INC. | $46.18 | 2025 | |
| Philips North America LLC | $44.14 | 2020-2022 | |
| Cardiva Medical, INC. | $34.33 | 2021 | |
| Innovation Technologies INC | $25.44 | 2023 | Irrisept |
| Abbott Laboratories | $23.58 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Biotronik INC. | $20.50 | 2020 | |
| Novo Nordisk INC | $19.22 | 2025 | Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.